logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Halozyme Shares Spike on Breast Cancer Drug Recommendation

By  +Follow June 28, 2013 12:21PM
Share:
Tickers Mentioned:

Shares of Halozyme (HALO) spiked in afternoon trading june 28 after its partner Roche Holding AG (RHHBY) received a positive recommendation from a European advisory committee on its injectable form of Herceptin, a breast cancer drug.

According to Halozyme CEO Gregory Frost, a Phase 3 study on Herceptin indicated that the drug “may help decrease the time patients spend receiving treatment at a hospital or physician’s practice, by reducing the administration time.” Halozyme produces an enzyme for Herceptin that now allows it to be injected subcutaneously.

A typical IV infusion of Herceptin takes 30-90 minutes, but Herceptin can now be administered in just two to five minutes via injection under the skin. Roche is currently seeking European approval for the injectable drug, so the recommendation is a very encouraging sign.

“Pending European approval, this subcutaneous formulation of Herceptin will provide a new route of administration that could potentially save time for both physicians and HER2-positive breast cancer patients in Europe,” Frost said. The breakthrough could be a complete game changer in the breast cancer drug space, as treatments are usually time consuming for both patients and doctors.

Halozyme shares spiked during trading hours on June 28 when the news was released. The stock reached a daily high of $8.20, a gain of around 30 percent since close on June 27.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com and Connect With Your Favorite Financial Experts FOR FREE! Members of Equities.com gain access to our leading financial news and content, active social investment community, proprietary research tools including the 2014 Small-Cap Stars, E.V.A. reports and more.

Results for HALO
Stockaholics
22 Oct 14 14:46:54
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/H5HPSVIRF1 $HALO $HSTM $NTIC
Aniu Student
22 Oct 14 13:31:19
@fezziwig2008 1st u say a Roche buyout,then $BAX,now $CELG!? U even said 2 much n a tweet stating u needed a b/o rumor 4 $HALO 2 c $18 again
fezziwig2008
22 Oct 14 13:22:41
$HALO Awarded a US Patent last Year for Hyaluronan Degrading Enzyme to Treat Benign Prostatic Hyperplasia- what next? http://t.co/FMgp8eRdBK
fezziwig2008
22 Oct 14 12:39:05
$CELG Lists 20 companies they share R&D with: https://t.co/BUzGZAv1Lv But their $3B Abraxane is in $HALO Ph2 PegpH20 Study w No Mention-Why?
Stockaholics
22 Oct 14 11:36:32
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $WFR $HALO $PNK
4-traders.com
22 Oct 14 11:25:07
Halozyme Therapeutics : FDA approves more manufacturing facilities for Halozyme's Hylenex recombinant produ... http://t.co/HhAvdj0CpH $HALO
fezziwig2008
22 Oct 14 11:02:41
$HALO added Abraxane to PegpH20-Gem Pancreatic Ca Regimen 4/22/13- $CELG acquired Abrax in 2010- Anyone See the Terms of the HALO-CELG Deal?
Stockaholics
22 Oct 14 10:54:00
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $HALO $HSTM $NTIC
fezziwig2008
22 Oct 14 10:43:08
When PegpH20 Doubles Abraxane's Med Overall Surv in Panc Ca & NSC Lung Ca-How are $CELG $HALO going to divide the Revenue? Won't have to...
fezziwig2008
22 Oct 14 09:59:37
Xmas may come just after $Halo ween this yr-Non Small Cell Lung Ca Partner a Non Small Catalyst w Large Ramifications-few shopping days left
fezziwig2008
22 Oct 14 08:27:39
Veeoz US Edition Covers CS Behring's Desparate Attempt to Save their Subcut Ig Business from $BAX $HALO HyQvia... http://t.co/WQ9h9f1Zdx
Me Likeitalot
22 Oct 14 07:05:15
$HALO Looks like someone with many shares gets hit on a tight trailing stop - see no logical reason to sell this stock right here,my opinion
biotech 2050
22 Oct 14 06:41:32
RT @fezziwig2008: 2 New FDA Approved Facilities making rhupH20 for $RHHBY subcut Cleopatra protocol , NHL and CLL Rx by MabTheraSC and Hyle…
fezziwig2008
22 Oct 14 06:40:34
2 New FDA Approved Facilities making rhupH20 for $RHHBY subcut Cleopatra protocol , NHL and CLL Rx by MabTheraSC and Hylenex for Diab $HALO
Peter Bardens
22 Oct 14 06:32:03
$HALO Halozyme Therapeutics Raised to "Outperform" at Zacks (HALO) http://t.co/P5eUoQ1p9S
Pinky G Felinious
22 Oct 14 05:57:34
@fezziwig2008 And when the pts. recur or fail mm-121 will be added to the regimen. $halo $mack
biotech 2050
22 Oct 14 05:44:23
RT @fezziwig2008: Updated 10/20/14 The Future of Br Ca Care- IV Perjeta plus Herceptin SC http://t.co/jGUQbthO8f Cleopatra combn extended l…
fezziwig2008
22 Oct 14 05:40:47
Updated 10/20/14 The Future of Br Ca Care- IV Perjeta plus Herceptin SC http://t.co/jGUQbthO8f Cleopatra combn extended life 15.7 mo $HALO
Thomas Collins
22 Oct 14 05:31:44
$HALO Halozyme Therapeutics Raised to "Outperform" at Zacks (HALO) http://t.co/s3p1hosY4x
Stockaholics
22 Oct 14 00:35:56
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $WFR $HALO $PNK
Stockaholics
21 Oct 14 22:23:27
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $HALO $HSTM $NTIC
Stock_Tracker
21 Oct 14 18:08:53
Halozyme Therapeutics (HALO) 9.12 $HALO NewLink-Roche Ink Deal for Oncology Candidate Development - Analyst Bl http://t.co/7i1fp1gnNP
Stockaholics
21 Oct 14 12:59:27
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $HALO $HSTM $NTIC
Me Likeitalot
21 Oct 14 12:55:30
$HALO Still huge gap to fill to the upside and someone is selling here now....lol. Sell me more Nov/Jan cheap calls please!
fezziwig2008
21 Oct 14 12:38:27
3 Sponsors of PegpH20 Ph2 Studies- Memorial Sloane Keterring Cancer Center, the NCI, and $HALO - standard stuff.
fezziwig2008
21 Oct 14 11:49:42
Factory Approvals, New Drug Approvals by EMA/FDA, New Patent - Yup Sounds- How Did Denzel Put it in "Philadelphia"?- "Very Satisfying" $HALO
DailyStockPicks
21 Oct 14 11:41:36
Earnings out for Owens Corning tomorrow. Is it due for a collapse? http://t.co/Est9NjxYUb $QIHU $ELRA $HALO $FITX $CANN $SEGI $SSYS $BIOF
fezziwig2008
21 Oct 14 10:19:08
PegpH20 will do almost as much for $HALO's Big BioPharma partner $CELG's Abraxane as it will for patients - NICE Just Nixed Abraxane
fezziwig2008
21 Oct 14 09:19:22
Barriers to Appvl Long Term Use FDA Appvd Hylenex(rhupH20) in Diabetes- 1. Safety>HyQvia (Ig+rhupH20) Appvl http://t.co/ylLTReuOvC 2. $HALO
fezziwig2008
21 Oct 14 07:22:30
Triangulation- $HALO now has FDA appvd Enzyme manufacuring facilities in Cal. Ind. & NC to service their own Diabetes Rx/HyQ/ $RHHBY =growth
biotech 2050
21 Oct 14 07:13:22
@Melikeitalot with $ZIOP $XON $TGTX $HALO one must have patience, stamina, perseverance, persistance, & self persuasion to hold on & relax:)
Phil Martin
21 Oct 14 04:07:37
$HALO http://t.co/e9MxjbgVhE
biotech 2050
21 Oct 14 02:57:46
RT @fezziwig2008: Modified FOLFIRINOX has improved safety/maintained efficacy in met Panc Ca http://t.co/aPbqctGhw0 Used w PegpH20 in NCI P…
biotech 2050
21 Oct 14 02:31:06
RT @fezziwig2008: @Biotech2050 NSC lung Ca combination probably named at the Q3 earnings call - usually 1st wk of November $halo
Gotham City Capital
21 Oct 14 02:22:57
RT @fezziwig2008: @novapharma n.b.-"significant progress in our planning for the EOY initiation of next PEGPH20 trial,which will be in nsc …
Gotham City Capital
21 Oct 14 02:22:52
RT @fezziwig2008: @Biotech2050 NSC lung Ca combination probably named at the Q3 earnings call - usually 1st wk of November $halo
fezziwig2008
21 Oct 14 02:20:41
@Biotech2050 NSC lung Ca combination probably named at the Q3 earnings call - usually 1st wk of November $halo
Stockaholics
21 Oct 14 00:19:38
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $WFR $HALO $PNK
biotech 2050
20 Oct 14 23:20:58
RT @fezziwig2008: @novapharma n.b.-"significant progress in our planning for the EOY initiation of next PEGPH20 trial,which will be in nsc …
Stockaholics
20 Oct 14 21:24:02
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $HALO $HSTM $NTIC
fezziwig2008
20 Oct 14 18:51:53
@novapharma n.b.-"significant progress in our planning for the EOY initiation of next PEGPH20 trial,which will be in nsc lung cancer" $HALO
NovaPharma
20 Oct 14 18:31:14
Some days it really is better to sit back and take some notes. $ARWR $KERX $HALO $TKMR $SPPI $OREX
Stockaholics
20 Oct 14 17:40:44
Our Penny Stock Picks Gained 371% In 2 Weeks! Get Our Next Pick Early: http://t.co/z2noBUWrEP $HALO $HSTM $NTIC
MAISA
20 Oct 14 17:14:41
$HALO $BAX Launches HYQVIA in the United States for Adult Patients with Primary Immunodeficiency
Quantheta
20 Oct 14 16:00:04
#SENTISHIFTUP $ZNGA $JPM $HALO $TRMB $CYTR $TLT $AIG $HLF $HXL $POT #quantheta
Ryan Gerry
20 Oct 14 15:36:24
@Pharmdca @adamfeuerstein he probably bitter his investment in $halo has gone to sg&it
Quantheta
20 Oct 14 14:00:03
#SENTISHIFTUP $ZNGA $JPM $HALO $TRMB $HLF $AIG $CYTR $TLT $MU $TDC #quantheta
Stockaholics
20 Oct 14 13:54:27
After Massive Gains On Penny Stock Picks, another New Pick Is Coming! Check it out: http://t.co/lWd4jUXeCy $WFR $HALO $PNK
Fred Feuerbach
20 Oct 14 13:20:37
RT @fezziwig2008: Can time the NSC Lung Ca Partner Announcement- early Nov Q3 Earnings Call-But Can't time FDA awarding of Hylenex Diabetes…
Stockaholics
20 Oct 14 13:15:56
After Massive Gains On Penny Stock Picks, another New Pick Is Coming! Check it out: http://t.co/lWd4jUXeCy $HALO $HSTM $NTIC
				
				
By  +Follow June 28, 2013 12:21PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.